Irreversible, uselektive monoaminoksidasehemmere
Year: 2009
Type: article
Abstract: Irreversible, non-selective monoamine oxidase (MAO) inhibitors were among the first antidepressants. No drugs in this group are currently marketed in Norway, but many physicians will see patients using them, as they can be prescribed on a named patient basis after application to the Norwegian Medicines Agency. This article presents adverse effects, interactions and precautions related to the use of these drugs.
Authors: Ingrid Castberg, Olav Spigset
Institution: St Olav's University Hospital
Language: Norwegian
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W210223755
